-
41
-
42
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
Published 2025-03-01Subjects: “…EGFR-mutated NSCLC…”
Get full text
Article -
43
Cytotoxic mechanisms of pemetrexed and HDAC inhibition in non-small cell lung cancer cells involving ribonucleotides in DNA
Published 2025-01-01Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text
Article -
44
The discovery and characterization of K‐563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp
Published 2019-03-01Subjects: Get full text
Article -
45
Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY
Published 2025-03-01Subjects: Get full text
Article -
46
-
47
A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
Published 2025-12-01Subjects: Get full text
Article -
48
BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
Published 2025-02-01Subjects: “…non-small cell lung cancer (NSCLC)…”
Get full text
Article -
49
A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review
Published 2025-02-01Subjects: Get full text
Article -
50
The role of MRO as an M2 macrophage-associated gene in non-small cell lung cancer: insights into immune infiltration, prognostic significance, and therapeutic implications
Published 2025-01-01Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text
Article -
51
miR‐224‐5p Suppresses Non‐Small Cell Lung Cancer via IL6ST‐Mediated Regulation of the JAK2/STAT3 Pathway
Published 2025-01-01Subjects: Get full text
Article -
52
Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks
Published 2025-01-01Subjects: Get full text
Article -
53
IL-17 triggers PD-L1 gene transcription in NSCLC cells via TRIM31-dependent MEF2C K63-linked polyubiquitination
Published 2025-01-01Subjects: “…NSCLC…”
Get full text
Article -
54
-
55
Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
Published 2025-02-01Subjects: “…Epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC)…”
Get full text
Article -
56
-
57
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis
Published 2025-02-01Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text
Article -
58
Awake thoracic surgery for lung cancer treatment: where we are and future perspectives—our experience and review of literature
Published 2025-01-01Subjects: Get full text
Article -
59
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
Published 2025-03-01Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text
Article -
60
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Published 2025-02-01Subjects: “…non-small cell lung cancer (NSCLC)…”
Get full text
Article